Skip to content

GLP-1 cost: how much each medicine costs a month

By the glp1doses editorial team
Every number is checked against FDA labels and official price pages. How we check

The short answer

GLP-1 cost depends on how you pay. Manufacturer self-pay prices run from $149 a month for the lowest tablet strengths to $499 for the highest Ozempic dose. List prices are much higher: Trulicity's, for example, is $1,006.93. If your commercial insurance covers the drug, a savings card can bring a fill down to as little as $25. Eligible Medicare Part D patients pay $50 through the Medicare GLP-1 Bridge.

Source: LillyDirect self-pay

Key takeaways

  • How you pay changes your price more than which medicine you take, so check your coverage first.
  • If commercial insurance covers the drug, a savings card can lower a fill to as little as $25.
  • On Medicare Part D? Savings cards are out. For weight management, eligible patients pay $50 through the Bridge.
  • Paying cash? Manufacturer self-pay programs start at $149 a month.
  • Budget thirteen fills a year for weekly injections, and add any provider membership to your monthly cost.

What you pay for a GLP-1 medicine in the United States depends far more on how you pay than on which medicine you take. The same box can cost $25 with a savings card, $50 through Medicare’s Bridge program, a few hundred dollars through a manufacturer’s cash program, or more than a thousand at list price. This guide explains each route, who can use it, and the rules that can change your bill. Every price here comes from the same price records that run our cost calculator, and each one links to its source.

What does a GLP-1 cost per month?

There are four price levels, and most people only ever see one of them.

List price. This is the price the manufacturer publishes before any discount. Per fill, it’s $1,349.02 for the Wegovy pen and the Wegovy pill, $1,027.51 for an Ozempic pen, $1,112.16 for Mounjaro, $1,006.93 for Trulicity, $1,349.02 for Saxenda and $649 for Foundayo. For Zepbound, Lilly publishes a range instead of one figure, from $499 to $1,086.37 per fill.

Manufacturer self-pay price. Lilly and Novo Nordisk both sell directly to people who pay cash. These prices start at $149 a month for Foundayo and $149 for the Wegovy pill, $299 for Zepbound, $389 for Trulicity and $499 for Mounjaro.

Savings-card price. If you have commercial insurance that covers the medicine, a manufacturer card can lower a fill to as little as $25.

Medicare Bridge copay. Eligible Part D patients pay $50 per one-month supply of a covered GLP-1 for weight management.

Your coverage decides which level applies to you, so start there. Call the number on your insurance card and ask two things: is the medicine on your plan’s formulary (its list of covered drugs), and does it need prior authorization (the plan’s approval before it pays)?

Why is the list price so much higher than what people pay?

The list price, also called the wholesale acquisition cost, is what the manufacturer charges wholesalers. Lilly says the prices patients pay at the pharmacy may be different, and that they largely depend on the out-of-pocket costs set by their insurer, pharmacy charges, and any discounts or financial assistance. Novo Nordisk says most people don’t pay list price if their insurance covers the medicine.

You’d still face the list price in one situation: you fill at a retail pharmacy, your plan doesn’t cover the drug, and no manufacturer offer has been applied. For most of the medicines here you can avoid that, because a self-pay program price exists. You can’t avoid it for every form. The Zepbound single-dose pen has no self-pay program price.

Novo Nordisk has announced a list price of $675 per month for Wegovy, Ozempic and Rybelsus starting January 1, 2027. The company also says Rybelsus is being replaced by the Ozempic pill and that Saxenda will be discontinued after January 2027.

How do the manufacturer self-pay programs work?

Both programs are for people paying cash. You don’t use insurance, and you can’t ask an insurer to pay you back afterward. You still need a prescription.

LillyDirect (Zepbound, Foundayo, Mounjaro, Trulicity)

LillyDirect is Lilly’s direct-to-patient pharmacy. Your prescriber sends the prescription to LillyDirect Pharmacy and a partner pharmacy fills it, with delivery or retail pickup.

  • Zepbound vials and the KwikPen cost $299 a month at 2.5 mg, $399 at 5 mg and $449 at 7.5 mg and above when you refill on time. Zepbound vials are sold only through LillyDirect self-pay. Needles are sold separately. Details are on the Zepbound cost page.
  • Foundayo tablets cost $149 a month at the lowest strength and $299 at the highest, again with on-time refills at the two top strengths. See Foundayo prices.
  • Mounjaro is $499 a month at every strength, and Trulicity is $389 a month at every strength.

A Lilly month is 28 days for Zepbound and 30 days for Foundayo. Lilly can change or end these offers at any time.

NovoCare Pharmacy (Wegovy, Ozempic)

NovoCare Pharmacy ships Wegovy and Ozempic to people who pay for it themselves, and you can use the same self-pay offer for pickup at a retail pharmacy.

  • Wegovy pill: $149 a month for 1.5 mg, $199 for 4 mg, and $299 for 9 mg and 25 mg.
  • Wegovy pen: if you’re new to the offer, you pay $199 a month for up to two monthly fills of 0.25 mg or 0.5 mg through December 31, 2026. After that the price is $349 a month for 0.25 mg to 2.4 mg, and $399 for the 7.2 mg HD pen. The Wegovy cost page has the full breakdown.
  • Ozempic pen: new patients pay $199 for the first two fills of 0.25 mg or 0.5 mg, then $349 for 0.25 mg, 0.5 mg or 1 mg. The 2 mg pen is $499. See Ozempic prices.

A Novo Nordisk month is one box of pens or one bottle of tablets. Novo Nordisk can change or cancel the offers at any time.

The without-insurance guide walks through the cheapest cash route for each medicine in turn.

How do manufacturer savings cards work?

A savings card isn’t the same thing as a self-pay price, and it’s for a different group: people with commercial (private or employer) drug insurance. If you’re on Medicare, Medicaid, TRICARE, VA or another government program, you can’t use any of these cards.

If your plan covers the drug, you pay as little as $25 per fill with a Lilly card or $25 a month with a Novo Nordisk offer. Pay attention to “as little as.” The manufacturer’s contribution is capped: for the Zepbound pen at $100 a month and $1,300 a year, for Mounjaro at $150 a month and $1,950 a year, and for the Wegovy, Ozempic and Rybelsus offers at $100 per one-month fill. If your plan’s copay (your share of the price) is higher than the cap plus the card price, you pay the difference.

If your commercial plan doesn’t cover the drug, Lilly has a separate offer that sets a fixed monthly price: $499 for the Zepbound single-dose pen and for Mounjaro, and by-dose prices for the Zepbound KwikPen and Foundayo. Lilly’s cards expire on 12/31/2026.

You’ll find each card, its cap and its exclusions on the savings cards page.

What is TrumpRx, and does it lower the price?

TrumpRx.gov is a federal price-listing site. You can’t buy medicine from it. It shows out-of-pocket prices for people who don’t use insurance, then hands you off: to LillyDirect for Zepbound vials and Foundayo, or to a coupon you show at a retail pharmacy for Wegovy and Ozempic.

The prices mirror the manufacturers’ own self-pay programs. Zepbound 2.5 mg is listed at $299, the Wegovy pill 1.5 mg at $149 and Ozempic 1 mg at $349, the same figures LillyDirect and NovoCare quote. The same conditions come with them, including the two-fill new-patient offer and Lilly’s refill window. Our TrumpRx explainer covers the terms.

What does Medicare pay for?

CMS, the agency that runs Medicare, says Medicare and Medicaid generally don’t cover GLP-1 drugs for weight loss. The exception is the Medicare GLP-1 Bridge, a temporary CMS demonstration that runs from July 1, 2026 through December 31, 2027. If you’re 18 or older, have Medicare Part D coverage and meet its BMI criteria, you pay a $50 copay per one-month supply of Foundayo tablets, the Wegovy pen or pill, or the Zepbound KwikPen. Zepbound single-dose vials and single-dose pens aren’t covered.

The copay is billed outside Part D, so it doesn’t count toward your deductible or out-of-pocket limit, and Extra Help doesn’t reduce it. If you already get a GLP-1 through Part D, or use one for type 2 diabetes, sleep apnea or fatty liver disease, you’re not eligible for the Bridge.

The Medicare guide explains the rules, the Bridge explainer goes through each criterion, and the Bridge eligibility checker asks the questions one at a time.

What do telehealth providers add to the price?

A telehealth provider is a way to get a prescription and support, not a separate source of cheaper medicine. Several publish medicine prices that match the manufacturers’ programs. Ro lists the Wegovy pen 2.4 mg at $349 and the Zepbound KwikPen 2.5 mg at $299, the same as NovoCare and LillyDirect.

The difference is the membership, billed on top of the medicine. At the standard monthly rate, the membership is $149 at Ro, $149 at Hims & Hers, $149 at LifeMD, $99 at Sesame, $79 at Mochi Health and $49 at Measured. Some providers discount the first month or longer prepaid terms.

So your true monthly cost through a provider is the medicine plus the membership. A medicine price that matches LillyDirect’s to the dollar still means a higher monthly bill once the fee is added. That can be worth paying. You need a prescriber from somewhere, and some programs include insurance paperwork, coaching or lab work. Our rankings add the membership to every provider price so you’re comparing like with like, and the cheapest path finder does the same for your own situation.

Not every provider price is a program price. Some list brand-name pens at well over a thousand dollars a month, so check the number before you enroll.

Why is a year 13 fills for injections?

Weekly injections are packed as a 28-day supply: 4 doses per fill. Fifty-two weeks divided into four-week fills is 13 fills, not twelve. So a “monthly” injection price is really a four-week price, and a year costs one fill more than twelve times the monthly figure.

Daily tablets are different. Foundayo and the Wegovy pill come as a 30-day supply, which makes 12 fills a year.

This changes how the medicines compare. A year of the Wegovy pen at 2.4 mg through NovoCare comes to $4,537, while a year of the Wegovy pill at 25 mg comes to $3,588. A year of Zepbound vials at 15 mg with on-time refills is $5,837, and a year of Foundayo at 17.2 mg is $3,588. Savings-card yearly caps are written with this in mind: the Zepbound pen card’s yearly cap equals thirteen monthly maximums.

What is the refill-window trap?

Two kinds of price come with conditions, and both can raise your bill without any announced price change.

Lilly’s 45-day window. For Zepbound 7.5 mg and up, and Foundayo 14.5 mg and 17.2 mg, the self-pay price is a Journey Program price. You get it on your first fill at that dose and on every refill you buy within 45 days of getting the previous fill. Miss the window and the regular price applies: $499 for Zepbound 7.5 mg, $699 for 10 mg, 12.5 mg and 15 mg, and $349 for the two top Foundayo strengths. At Zepbound 15 mg, one late refill costs you the difference between $449 and $699. The 45-day rule page explains how the window is counted, and the supply tracker shows your last on-time refill date.

Novo Nordisk’s new-patient price. The $199 price for the two lowest Wegovy pen and Ozempic doses lasts for two monthly fills only. From the third fill the price is $349. Budget on the later price, not the introductory one.

How to find your lowest price

  1. Check your coverage first. If a commercial plan covers the drug, the savings-card price is lower than any cash price. If the plan says no, ask about prior authorization before you give up. The appeal letter generator drafts the request.
  2. If you have Medicare Part D, check the Bridge criteria before you pay cash. You can’t use savings cards, but the Bridge copay is lower than any self-pay price.
  3. If you’re paying cash, compare the manufacturer’s program price for the form and dose you’re prescribed. The form matters: vials and KwikPens for Zepbound, pen or pill for Wegovy. The pen vs vial vs pill comparer shows the difference per fill.
  4. Add every fee. A provider membership, pen needles or syringes, and a late-refill price all belong in your monthly figure.
  5. Price the year, not the month. Use thirteen fills for weekly injections and include the dose steps you expect. The calculator does this from the label’s schedule.

Each medicine has its own cost page with every price for it: Zepbound, Mounjaro, Wegovy, Ozempic, Foundayo, Rybelsus, Saxenda and Trulicity.

Where these prices come from

We read every price on the manufacturer’s, the government’s or the provider’s own page and record it with its conditions and a link to that page. The full set is published as the GLP-1 Price Index, and the method is on how we verify prices.

Frequently asked questions

How much does a GLP-1 cost per month without insurance?

Through the manufacturers' own self-pay programs, a month costs from $149 for the lowest Foundayo and Wegovy pill strengths up to $449 for the higher Zepbound doses and $499 for Ozempic 2 mg. Through LillyDirect, Mounjaro is $499 a month and Trulicity is $389 a month. These are cash prices. You don't use insurance, and you can't claim the cost back.

What is the cheapest GLP-1 without insurance?

At the starting strengths, the lowest manufacturer self-pay prices are Foundayo tablets at $149 a month through LillyDirect and the Wegovy pill at $149 a month through NovoCare. Prices rise with the dose, so the cheapest medicine at the start isn't always the cheapest at the dose you end up on. Which medicine is right for you is your prescriber's decision, not a price decision.

Why is the list price of a GLP-1 so high if nobody pays it?

The list price is what the manufacturer charges wholesalers before any discount or rebate. Lilly says the price patients pay largely depends on their insurance, pharmacy charges and any savings program, and Novo Nordisk says most people with coverage don't pay list price. It still matters if you fill at a retail pharmacy with no coverage and no manufacturer offer applied.

Can I use a GLP-1 savings card with Medicare or Medicaid?

No. The Lilly and Novo Nordisk savings cards are for people with commercial (private or employer) drug insurance. If you're enrolled in Medicare, Medicaid, TRICARE, VA or another government program, you can't use them. For weight management, Medicare Part D patients who meet the criteria can use the Medicare GLP-1 Bridge instead, with a $50 copay per one-month supply.

Is TrumpRx cheaper than buying from the manufacturer?

No. TrumpRx.gov lists the same self-pay prices as the manufacturers' own programs. For Zepbound vials and Foundayo, it sends you to LillyDirect to buy. For Wegovy and Ozempic, it gives you a coupon to show at a retail pharmacy. It's a price-listing site, not a pharmacy, and the prices are for people who don't use insurance.

How many GLP-1 fills are there in a year?

Weekly injections such as Zepbound, Wegovy pens and Ozempic come as a 28-day supply, so you get 13 fills a year, not twelve. Daily tablets such as Foundayo and the Wegovy pill come as a 30-day supply, which makes 12 fills. If you multiply a monthly injection price by twelve, you'll come up one fill short for the year.

What is the 45-day refill rule?

Lilly's lower self-pay price for Zepbound 7.5 mg and above, and for Foundayo 14.5 mg and 17.2 mg, applies to your first fill at that dose and to refills you buy within 45 days of getting the previous one. Miss that window and the regular price applies: up to $699 for Zepbound and $349 for Foundayo.

Do telehealth providers charge more for the same medicine?

Often the medicine price matches the manufacturer's, but a membership is billed on top. At their standard monthly rate, Ro and Hims & Hers each charge $149 a month, Sesame charges $99 and Mochi Health charges $79. Add the membership to the medicine price to get your true monthly cost. That fee pays for the prescriber visit and support, which you need from someone either way.

Will GLP-1 prices change in 2027?

Some changes have been announced. Novo Nordisk has announced a list price of $675 per month for Wegovy, Ozempic and Rybelsus starting January 1, 2027. Lilly's savings cards expire on 12/31/2026, and the Wegovy and Ozempic new-patient offer runs through December 31, 2026. Check the price with the program before you fill.

Sources (20)

  1. 1.
    CMS: BALANCE (Better Approaches to Lifestyle and Nutrition for Comprehensive hEalth) Model
    “GLP-1 drugs for weight loss, along with lifestyle interventions, can help people improve their overall health, but GLP-1s are expensive and currently Medicare and Medicaid generally do not cover these drugs for the weight loss indication.”
  2. 2.
  3. 3.
  4. 4.
  5. 5.
  6. 6.
  7. 7.
  8. 8.
  9. 9.
  10. 10.
  11. 11.
  12. 12.
  13. 13.
  14. 14.
  15. 15.
  16. 16.
  17. 17.
  18. 18.
  19. 19.
  20. 20.